Abstract
Purpose
The purpose of this study was to measure the association between peripheral neuropathy symptoms and depressive symptoms among a sample of patients with and without diabetes mellitus (DM).
Methods
Patients were administered the 15-item Michigan Neuropathy Screening Instrument (MNSI) and the patient health questionnaire depression scale (PHQ-8). Patients with an MNSI score ≥ 4 were categorized as having PN and patients with a PHQ-8 score ≥ 10 were considered to have current depression. Log-binomial regression was used to analyze the relationship between PN and depressive symptoms.
Results
406 patients were included in the final analysis. There were no statistically significant differences by diabetes status in PN symptoms (Diabetes = 61.8%; No diabetes = 55.4%; p = .20) or in depression status (Diabetes = 37.6%; No diabetes = 36.6%; p = .83). After adjustment for covariates, PN was associated with depression (aRR = 4.46; 95% CI 2.91,6.85) independent of diabetes status.
Conclusions
PN symptoms may be common among aging persons even in the absence of DM. Past literature and our study demonstrate that PN and depression are closely associated. More work is needed to understand the etiology and potential utility of intervention for depression symptoms among patients with neuropathy.
Similar content being viewed by others
Data availability
Data used for this study was not deidentified because it was analyzed on-site at a medical facility. Data for this study are not allowed to be analyzed outside of the Waco Family Health Center.
Code availability
SAS code will be made available upon request.
References
Juster-Switlyk, K., & Smith, A. G. (2016). Updates in diabetic peripheral neuropathy. F1000 Research. https://doi.org/10.12688/f1000research.7898.1.
Gregg, E. W., Sorlie, P., Paulose-Ram, R., et al. (2004). Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999–2000 National Health and Nutrition Examination Survey. Diabetes Care, 27(7), 1591–1597. https://doi.org/10.2337/diacare.27.7.1591.
Stino, A. M., & Smith, A. G. (2017). Peripheral neuropathy in prediabetes and the metabolic syndrome. Journal of Diabetes Investigation, 8(5), 646–655. https://doi.org/10.1111/jdi.12650.
Ylitalo, K. R., Sowers, M., & Heeringa, S. (2011). Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity. Diabetes Care, 34(7), 1642–1647. https://doi.org/10.2337/dc10-2150.
Miscio, G., Guastamacchia, G., Brunani, A., Priano, L., Baudo, S., & Mauro, A. (2005). Obesity and peripheral neuropathy risk: a dangerous liaison. Journal of the Peripheral Nervous System, 10(4), 354–358. https://doi.org/10.1111/j.1085-9489.2005.00047.x.
Farhad, K., Traub, R., Ruzhansky, K. M., & Brannagan, T. H. (2016). Causes of neuropathy in patients referred as “idiopathic neuropathy”: Causes of Neuropathy. Muscle and Nerve, 53(6), 856–861. https://doi.org/10.1002/mus.24969.
Gordon Smith, A., & Robinson, S. J. (2006). Idiopathic neuropathy, prediabetes and the metabolic syndrome. Journal of the Neurological Sciences, 242(1–2), 9–14. https://doi.org/10.1016/j.jns.2005.11.020.
Baron, R., Binder, A., & Wasner, G. (2010). Review neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. The Lancet Neurology, 9(8), 807–819.
Boulton, A. J. M. (2005). Management of diabetic peripheral neuropathy. Clinical Diabetes, 23(1), 9–15. https://doi.org/10.2337/diaclin.23.1.9.
Vileikyte, L., Leventhal, H., Gonzalez, J. S., et al. (2005). Diabetic peripheral neuropathy and depressive symptoms: The association revisited. Diabetes Care, 28(10), 2378–2383. https://doi.org/10.2337/diacare.28.10.2378.
Vileikyte, L., Peyrot, M., Gonzalez, J. S., et al. (2009). Predictors of depressive symptoms in persons with diabetic peripheral neuropathy: A longitudinal study. Diabetologia, 52(7), 1265–1273. https://doi.org/10.1007/s00125-009-1363-2.
Bai, J.-W., Lovblom, L. E., Cardinez, M., et al. (2017). Neuropathy and presence of emotional distress and depression in longstanding diabetes: Results from the Canadian study of longevity in type 1 diabetes. Journal of Diabetes and Its Complications, 31(8), 1318–1324. https://doi.org/10.1016/j.jdiacomp.2017.05.002.
Gormsen, L., Rosenberg, R., Bach, F., & Jensen, T. (2010). Depression, anxiety, health-related quality of life and pain in patients with chronic fibromyalgia and neuropathic pain. European Journal of Pain, 14(2), 127.e1–127.e8. https://doi.org/10.1016/j.ejpain.2009.03.010.
Yoshida, S., Hirai, M., Suzuki, S., Awata, S., & Oka, Y. (2009). Neuropathy is associated with depression independently of health-related quality of life in Japanese patients with diabetes. Psychiatry and Clinical Neurosciences, 63(1), 65–72. https://doi.org/10.1111/j.1440-1819.2008.01889.x.
Pan, S., Liu, Z.-W., Shi, S., et al. (2017). Hamilton rating scale for depression-24 (HAM-D 24) as a novel predictor for diabetic microvascular complications in type 2 diabetes mellitus patients. Psychiatry Research, 258, 177–183. https://doi.org/10.1016/j.psychres.2017.07.050.
Feldman, E. L., Stevens, M. J., Thomas, P. K., Brown, M. B., Canal, N., & Greene, D. A. (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17(11), 1281–1289. https://doi.org/10.2337/diacare.17.11.1281.
Herman, W. H., Pop-Busui, R., Braffett, B. H., et al. (2012). Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications. Diabetic Medicine, 29(7), 937–944. https://doi.org/10.1111/j.1464-5491.2012.03644.x.
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2001). The PHQ-9. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.
Kroenke, K., Strine, T. W., Spitzer, R. L., Williams, J. B. W., Berry, J. T., & Mokdad, A. H. (2009). The PHQ-8 as a measure of current depression in the general population. Journal of Affective Disorders, 114(1–3), 163–173. https://doi.org/10.1016/j.jad.2008.06.026.
Wells, T. S., Horton, J. L., LeardMann, C. A., Jacobson, I. G., & Boyko, E. J. (2013). A comparison of the PRIME-MD PHQ-9 and PHQ-8 in a large military prospective study, the Millennium Cohort Study. Journal of Affective Disorders, 148(1), 77–83. https://doi.org/10.1016/j.jad.2012.11.052.
Dhingra, S. S., Kroenke, K., Zack, M. M., Strine, T. W., & Balluz, L. S. (2011). PHQ-8 Days: A measurement option for DSM-5 major depressive disorder (MDD) severity. Population Health Metrics. https://doi.org/10.1186/1478-7954-9-11.
Spiegelman, D., & Easy, S. A. S. (2005). Calculations for risk or prevalence ratios and differences. American Journal of Epidemiology, 162(3), 199–200. https://doi.org/10.1093/aje/kwi188.
D’Amato, C., Morganti, R., Greco, C., et al. (2016). Diabetic peripheral neuropathic pain is a stronger predictor of depression than other diabetic complications and comorbidities. Diabetes & Vascular Disease Research, 13(6), 418–428. https://doi.org/10.1177/1479164116653240.
Rekleiti, M., Sarafis, P., Saridi, M., et al. (2013). Investigation of depression in greek patients with diabetic peripheral neuropathy. Global Journal of Health Science, 5(5), 107–114. https://doi.org/10.5539/gjhs.v5n5p107.
Raval, A., Dhanaraj, E., Bhansali, A., Grover, S., & Tiwari, P. (2010). Prevalence & determinants of depression in type 2 diabetes patients. Indian Journal of Medical Research, 132(2), 195.
Stankovik, Ž. (2010). Psychosocial and clinical variables associated with depression in patients with type 2 diabetes. Psychiatria Danubina, 23(1), 11.
Ishizawa, K., Babazono, T., Horiba, Y., et al. (2016). The relationship between depressive symptoms and diabetic complications in elderly patients with diabetes: Analysis using the Diabetes Study from the Center of Tokyo Women’s Medical University (DIACET). Journal of Diabetes and Its Complications, 30(4), 597–602. https://doi.org/10.1016/j.jdiacomp.2016.02.004.
Rodda, J., Walker, Z., & Carter, J. (2011). Depression in older adults. BMJ, 343, d5219. https://doi.org/10.1136/bmj.d5219.
Cuijpers, P., de Graaf, R., & van Dorsselaer, S. (2004). Minor depression: risk profiles, functional disability, health care use and risk of developing major depression. Journal of Affective Disorders, 79(1–3), 71–79. https://doi.org/10.1016/S0165-0327(02)00348-8.
Lewis Brown, R., & Turner, R. J. (2010). Physical disability and depression: Clarifying racial/ethnic contrasts. Journal of Aging and Health, 22(7), 977–1000. https://doi.org/10.1177/0898264309360573.
Verbrugge, L. M., & Jette, A. M. (1994). The disablement process. Social Science & Medicine, 38(1), 1–14.
Resnick, H. E., Vinik, A. I., Schwartz, A. V., et al. (2000). Independent effects of peripheral nerve dysfunction on lower-extremity physical function in old age: The Women’s Health and Aging Study. Diabetes Care, 23(11), 1642–1647. https://doi.org/10.2337/diacare.23.11.1642.
Karvonen-Gutierrez, C. A., & Ylitalo, K. R. (2013). Prevalence and correlates of disability in a late middle-aged population of women. Journal of Aging and Health, 25(4), 701–717. https://doi.org/10.1177/0898264313488165.
Tesfaye, S. (2019). Neuropathy in diabetes. Medicine (Baltimore), 47(2), 92–99. https://doi.org/10.1016/j.mpmed.2018.11.009.
Iqbal, Z., Azmi, S., Yadav, R., et al. (2018). Diabetic peripheral neuropathy: Epidemiology, diagnosis, and pharmacotherapy. Clinical Therapeutics, 40(6), 828–849. https://doi.org/10.1016/j.clinthera.2018.04.001.
England, J. D., Gronseth, G. S., Franklin, G., et al. (2009). Practice Parameter: Evaluation of distal symmetric polyneuropathy: Role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review): Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, and American Academy of Physical Medicine and Rehabilitation. Neurology., 72(2), 177–184. https://doi.org/10.1212/01.wnl.0000336345.70511.0f.
U.S. Preventive Services Task Force. Published Recommendations-US Preventive Services Task Force. Published June 2019. Accessed June 20, 2019. https://www.uspreventiveservicestaskforce.org/BrowseRec/Index.
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., et al. (2017). Diabetic neuropathy: A position statement by the american diabetes association. Diabetes Care, 40(1), 136–154. https://doi.org/10.2337/dc16-2042.
Watson, J. C., & Dyck, P. J. B. (2015). Peripheral neuropathy: A practical approach to diagnosis and symptom management. Mayo Clinic Proceedings, 90(7), 940–951. https://doi.org/10.1016/j.mayocp.2015.05.004.
Abresch, R. T., Jensen, M. P., & Carter, G. T. (2001). Health-related quality of life in peripheral neuropathy. Physical Medicine and Rehabilitation Clinics of North America, 12(2), 461–472.
Sivertsen, H., Bjørkløf, G. H., Engedal, K., Selbæk, G., & Helvik, A.-S. (2015). Depression and quality of life in older persons: A review. Dementia and Geriatric Cognitive Disorders, 40(5–6), 311–339. https://doi.org/10.1159/000437299.
Acknowledgements
The authors of this study would like to thank the Waco Family Health Center for their continued partnership with the Baylor University Department of Public Health that made this study possible.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Jackson Griggs currently serves as the Chief Executive Officer of the Waco Family Health Center. Besides this employment, no authors have any conflicts of interest to report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Benavidez, G.A., Ylitalo, K.R., Lanning, B. et al. Peripheral neuropathy and depressive symptoms: examining the association in a primary health care setting among persons with and without diabetes mellitus. Qual Life Res 29, 3297–3304 (2020). https://doi.org/10.1007/s11136-020-02579-2
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11136-020-02579-2